Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model

Muscal, 2010, Neurologic manifestations of systemic lupus erythematosus in children and adults, Neurol Clin, 28, 61, 10.1016/j.ncl.2009.09.004 Appenzeller, 2006, Neurolupus Arch Neurol, 63, 458, 10.1001/archneur.63.3.458 McGlasson, 2018, Neurological disease in lupus: toward a personalized medicine approach, Front Immunol, 9, 1146, 10.3389/fimmu.2018.01146 Jeltsch-David, 2014, Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers, Nat Rev Neurol, 10, 579, 10.1038/nrneurol.2014.148 Joseph, 2010, Neurolupus Pract Neurol, 10, 4, 10.1136/jnnp.2009.200071 Mackay, 2015, Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus, Immunol Res, 63, 26, 10.1007/s12026-015-8716-3 Manzi, 1997, Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study, Am J Epidemiol, 145, 408, 10.1093/oxfordjournals.aje.a009122 Du, 2017, Molecular mechanisms of vascular dementia: what can Be learned from animal models of chronic cerebral hypoperfusion?, Mol Neurobiol, 54, 3670, 10.1007/s12035-016-9915-1 Gorelick, 2011, Stroke, 42, 2672, 10.1161/STR.0b013e3182299496 Østergaard, 2016, Cerebral small vessel disease: capillary pathways to stroke and cognitive decline, J Cerebr Blood Flow Metabol, 36, 302, 10.1177/0271678X15606723 Pamfil, 2015, EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres, Rheumatology, 54, 1270, 10.1093/rheumatology/keu482 Baur, 2006, Therapeutic potential of resveratrol: the in vivo evidence, Nat Rev Drug Discov, 5, 493, 10.1038/nrd2060 Hung, 2000, Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes, Cardiovasc Res, 47, 549, 10.1016/S0008-6363(00)00102-4 Singh, 2010, Resveratrol (trans-3,5,4'-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis, J Pharmacol Exp Therapeut, 332, 829, 10.1124/jpet.109.160838 Wightman, 2015, The effects of chronic transresveratrol supplementation on aspects of cognitive function, mood, sleep, health and cerebral blood flow in healthy, young humans, Br J Nutr, 114, 1427, 10.1017/S0007114515003037 Vasamsetti, 2016, Resveratrol attenuates monocyte-tomacrophage differentiation and associated inflammation via modulation of intracellular GSH homeostasis: relevance in atherosclerosis, Free Radic Biol Med, 96, 392, 10.1016/j.freeradbiomed.2016.05.003 Voloshyna, 2013, Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPAR-γ and adenosine, Eur J Pharmacol, 698, 299, 10.1016/j.ejphar.2012.08.024 Voloshyna, 2016, Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux, Exp Biol Med, 241, 1611, 10.1177/1535370216647181 Feng, 2007, ApoE−/−Fas−/− C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia, J Lipid Res, 48, 794, 10.1194/jlr.M600512-JLR200 Piedrahita, 1992, Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells, Proc Natl Acad Sci U S A, 89, 4471, 10.1073/pnas.89.10.4471 Croker, 2003, Genetic interactions between susceptibility loci reveal epistatic pathogenic networks in murine lupus, Gene Immun, 4, 575, 10.1038/sj.gene.6364028 Bendorius, 2018, From systemic inflammation to neuroinflammation: the case of neurolupus, Int J Mol Sci, 19, 10.3390/ijms19113588 Duarte-García, 2018, Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with Systemic Lupus Erythematosus and Cognitive Dysfunction, PLoS One, 13, 10.1371/journal.pone.0196487 Shastri, 2016, MR diffusion tractography to identify and characterize microstructural white matter tract changes in systemic lupus erythematosus patients, Acad Radiol, 23, 1431, 10.1016/j.acra.2016.03.019 Afeltra, 2003, Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies, Neurology, 61, 108, 10.1212/01.WNL.0000058904.94330.A7 Brey, 2002, Neuropsychiatric syndromes in lupus: prevalence using standardized definitions, Neurology, 58, 10.1212/WNL.58.8.1214 Karaaslan, 2017, Investigation of neuronal auto-antibodies in systemic lupus erythematosus patients with epilepsy, Epilepsy Res, 129, 132, 10.1016/j.eplepsyres.2016.12.006 McLean, 1995, Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system, J Neurol Neurosurg Psychiatry, 58, 548, 10.1136/jnnp.58.5.548 Tan, 2018, Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus, Clin Rheumatol, 37, 227, 10.1007/s10067-017-3891-3 Böckle, 2014, Cerebral large vessel vasculitis in systemic lupus erythematosus, Lupus, 23, 1417, 10.1177/0961203314541689 Taha, 2017, Vascular endothelial growth factor G1612A (rs10434) gene polymorphism and neuropsychiatric manifestations in systemic lupus erythematosus patients, Rev Bras Reumatol Engl Ed, 57, 149, 10.1016/j.rbr.2016.08.005 Oliveira, 2016, Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice, Brain Res, 1644, 149, 10.1016/j.brainres.2016.05.013 Kalinowska-Łyszczarz, 2018, Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients, Lupus, 27, 610, 10.1177/0961203317735186 Li, 2018, The corticostriatal adenosine A2A receptor controls maintenance and retrieval of spatial working memory, Biol Psychiatr, 83, 530, 10.1016/j.biopsych.2017.07.017 Cunha, 2008, Different cellular sources and different roles of adenosine: a1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity, Neurochem Int, 52, 65, 10.1016/j.neuint.2007.06.026 Ferrante, 2018, The adenosine A2A receptor agonist T1-11 ameliorates neurovisceral symptoms and extends the lifespan of a mouse model of Niemann-Pick type C disease, Neurobiol Dis, 110, 1, 10.1016/j.nbd.2017.10.013 Reiss, 2012, Regulation of foam cells by adenosine, Arterioscler Thromb Vasc Biol, 32, 879, 10.1161/ATVBAHA.111.226878 Reiss, 2004, Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages, J Leukoc Biol, 76, 727, 10.1189/jlb.0204107 Chen, 2018, Adenosine A2A receptor involves in neuroinflammation-mediated cognitive decline through activating microglia under acute hypobaric hypoxia, Behav Brain Res, 347, 99, 10.1016/j.bbr.2018.02.038 Suzuki, 2017, Istradefylline improves daytime sleepiness in patients with Parkinson's disease: an open-label, 3-month study, J Neurol Sci, 380, 230, 10.1016/j.jns.2017.07.045 Bobermin, 2019, Adenosine receptors as a new target for resveratrol-mediated glioprotection, Biochim Biophys Acta (BBA) - Mol Basis Dis, 1865, 634, 10.1016/j.bbadis.2019.01.004 Zhang, 2017, Resveratrol attenuates microglial activation via SIRT1-SOCS1 pathway, Evid Based Compl Alternat Med, 2017, 8791832 Cope, 2018, Microglia play an active role in obesity-associated cognitive decline, J Neurosci, 38, 8889, 10.1523/JNEUROSCI.0789-18.2018 Xiao, 2017, Chitinase1 contributed to a potential protection via microglia polarization and Aβ oligomer reduction in D-galactose and aluminum-induced rat model with cognitive impairments, Neuroscience, 355, 61, 10.1016/j.neuroscience.2017.04.050 Hopperton, 2016, Brain omega-3 polyunsaturated fatty acids modulate microglia cell number and morphology in response to intracerebroventricular amyloid-β 1-40 in mice, J Neuroinflammation, 13, 257, 10.1186/s12974-016-0721-5 Porrini, 2015, CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid, Neuroscience, 302, 112, 10.1016/j.neuroscience.2014.10.029 Zameer, 2003, Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice, J Neuroimmunol, 142, 67, 10.1016/S0165-5728(03)00262-5 Pittet, 2019, Maternal social environment affects offspring cognition through behavioural and immune pathways in rats, J Neuroendocrinol, 10.1111/jne.12711 Kuban, 2017, Extremely low gestational age newborn (ELGAN) study investigators. Circulating inflammatory-associated proteins in the first month of life and cognitive impairment at age 10 Years in children born extremely preterm, J Pediatr, 180, 10.1016/j.jpeds.2016.09.054 Todd, 2017, Inflammation and cognition in older adults: evidence from taiwan, Biodemogr Soc Biol, 63, 309, 10.1080/19485565.2017.1403305 Brey, 1997, Anti-intercellular adhesion molecule-1 (ICAM-1) antibody treatment prevents central and peripheral nervous system disease in autoimmune-prone mice, Lupus, 6, 645, 10.1177/096120339700600805 Francioso, 2014, Chemistry, stability and bioavailability of resveratrol, Med Chem, 10, 237, 10.2174/15734064113096660053 Bastianetto, 2015, Neuroprotective action of resveratrol, Biochim Biophys Acta, 1852, 1195, 10.1016/j.bbadis.2014.09.011 Summerlin, 2015, Resveratrol nanoformulations: challenges and opportunities, Int J Pharm, 479, 282, 10.1016/j.ijpharm.2015.01.003 Andrade, 2018, Resveratrol brain delivery for neurological disorders prevention and treatment, Front Pharmacol, 9, 1261, 10.3389/fphar.2018.01261